Department of Gastroenterology and Hepatology, King Abdulaziz Hospital-National Guard, Ahsa 31982, Saudi Arabia.
Department of Internal Medicine, Faculty of Medicine, Zamzam University College, Khartoum 11113, Sudan.
World J Gastroenterol. 2024 Feb 21;30(7):742-758. doi: 10.3748/wjg.v30.i7.742.
In hepatology, the clinical use of endoscopic ultrasound (EUS) has experienced a notable increase in recent times. These applications range from the diagnosis to the treatment of various liver diseases. Therefore, this systematic review summarizes the evidence for the diagnostic and therapeutic roles of EUS in liver diseases.
To examine and summarize the current available evidence of the possible roles of the EUS in making a suitable diagnosis in liver diseases as well as the therapeutic accuracy and efficacy.
PubMed, Medline, Cochrane Library, Web of Science, and Google Scholar databases were extensively searched until October 2023. The methodological quality of the eligible articles was assessed using the Newcastle-Ottawa scale or Cochrane Risk of Bias tool. In addition, statistical analyses were performed using the Comprehensive Meta-Analysis software.
Overall, 45 articles on EUS were included (28 on diagnostic role and 17 on therapeutic role). Pooled analysis demonstrated that EUS diagnostic tests had an accuracy of 92.4% for focal liver lesions (FLL) and 96.6% for parenchymal liver diseases. EUS-guided liver biopsies with either fine needle aspiration or fine needle biopsy had low complication rates when sampling FLL and parenchymal liver diseases (3.1% and 8.7%, respectively). Analysis of data from four studies showed that EUS-guided liver abscess had high clinical (90.7%) and technical success (90.7%) without significant complications. Similarly, EUS-guided interventions for the treatment of gastric varices (GV) have high technical success (98%) and GV obliteration rate (84%) with few complications (15%) and rebleeding events (17%).
EUS in liver diseases is a promising technique with the potential to be considered a first-line therapeutic and diagnostic option in selected cases.
在肝脏病学领域,内镜超声(EUS)的临床应用近年来显著增加。这些应用涵盖了从肝脏疾病的诊断到治疗的各个方面。因此,本系统综述总结了 EUS 在肝脏疾病中的诊断和治疗作用的证据。
检查和总结 EUS 在肝脏疾病中进行适当诊断的可能作用以及治疗准确性和疗效的现有证据。
广泛检索了 PubMed、Medline、Cochrane 图书馆、Web of Science 和 Google Scholar 数据库,截至 2023 年 10 月。使用纽卡斯尔-渥太华量表或 Cochrane 偏倚风险工具评估合格文章的方法学质量。此外,使用 Comprehensive Meta-Analysis 软件进行了统计分析。
总共纳入了 45 篇关于 EUS 的文章(28 篇关于诊断作用,17 篇关于治疗作用)。汇总分析表明,EUS 诊断试验对局灶性肝脏病变(FLL)的准确性为 92.4%,对实质肝脏疾病的准确性为 96.6%。EUS 引导的肝脏活检,无论是细针抽吸还是细针活检,在取样 FLL 和实质肝脏疾病时的并发症发生率均较低(分别为 3.1%和 8.7%)。四项研究的数据分析表明,EUS 引导的肝脓肿具有较高的临床(90.7%)和技术成功率(90.7%),且无显著并发症。同样,EUS 引导的胃静脉曲张(GV)治疗干预具有较高的技术成功率(98%)和 GV 闭塞率(84%),并发症发生率较低(15%),再出血事件发生率(17%)。
EUS 在肝脏疾病中是一种很有前途的技术,有潜力在选定病例中被视为一线治疗和诊断选择。